Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Small GTPases are key signaling nodes that regulate the cellular processes and subcellular events, and their abnormal activities and dysregulations are closely linked with diverse cancers. Here, we report the development of conformation-selective protein binders for a KRAS mutant. The conformation-specific protein binders were selected from a repebody scaffold composed of LRR (Leucine-rich repeat) modules through phage display and modular engineering against constitute active conformation of KRAS. Epitope of the selected binders was mapped to be located close to switch I of KRAS. The conformation-selective protein binders were shown to effectively block the interaction between active KRAS and RAS-binding domain of BRAF, suppressing the KRAS-mediated downstream signaling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2023.01.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of conformation-selective antibodies targeting human SLC15A4.
Nat Commun
August 2025
State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
SLC15A4, an endolysosomal solute carrier family transporter, plays a critical role in TLR7/8/9-induced immune responses through assembling a complex with the downstream adaptor TASL in a conformation-dependent manner. Despite its close functional association and promising therapeutic potential in infections, tumors, and autoimmune diseases, the development of conformation-specific antibodies for human SLC15A4 (hSLC15A4) remains challenging. Here, using a systematic screening and validation approach, we identify a pair of conformation-selective antibodies, clones 107 and 235, targeting the endolysosomal lumen surface of hSLC15A4 with opposite conformation-regulatory activities.
View Article and Find Full Text PDFA cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation.
Nat Commun
November 2024
Protein-Protein Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Peptidylarginine deiminase IV (PADI4, PAD4) deregulation promotes the development of autoimmunity, cancer, atherosclerosis and age-related tissue fibrosis. PADI4 additionally mediates immune responses and cellular reprogramming, although the full extent of its physiological roles is unexplored. Despite detailed molecular knowledge of PADI4 activation in vitro, we lack understanding of its regulation within cells, largely due to a lack of appropriate systems and tools.
View Article and Find Full Text PDFStructure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist.
Nat Commun
October 2024
Confo Therapeutics N.V, Ghent, Belgium.
Article Synopsis
- The melanocortin receptor 4 (MC4R) is a crucial component in regulating hunger and fullness through its interaction with hormones like α-melanocyte-stimulating hormone and agouti-related peptide.
- Researchers developed a unique hybrid structure using a ConfoBody that helps them discover a variety of MC4R-specific, potent nanobodies that act as full agonists.
- The study revealed the structure of MC4R with a full agonistic nanobody at a high resolution, showing that this specific nanobody could potentially be more effective and targeted for anti-obesity treatments compared to existing peptide agonists.
Empowering AlphaFold2 for protein conformation selective drug discovery with AlphaFold2-RAVE.
Elife
September 2024
Institute for Physical Science and Technology, University of Maryland, College Park, United States.
Small-molecule drug design hinges on obtaining co-crystallized ligand-protein structures. Despite AlphaFold2's strides in protein native structure prediction, its focus on apo structures overlooks ligands and associated holo structures. Moreover, designing selective drugs often benefits from the targeting of diverse metastable conformations.
View Article and Find Full Text PDFSpecific glycine-dependent enzyme motion determines the potency of conformation selective inhibitors of threonyl-tRNA synthetase.
Commun Biol
July 2024
State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 200032, Shanghai, China.
The function of proteins depends on their correct structure and proper dynamics. Understanding the dynamics of target proteins facilitates drug design and development. However, dynamic information is often hidden in the spatial structure of proteins.
View Article and Find Full Text PDF